Ibutilide
- Generic Name
- Ibutilide
- Brand Names
- Corvert
- Drug Type
- Small Molecule
- Chemical Formula
- C20H36N2O3S
- CAS Number
- 122647-31-8
- Unique Ingredient Identifier
- 2436VX1U9B
- Background
Ibutilide is a Class III antiarrhythmic agent available in intravenous formulations. It is indicated for the conversion of acute atrial flutter and recent onset atrial fibrillation to normal sinus rhythm (NSR).
- Indication
Indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm.
- Associated Conditions
- Atrial Fibrillation, Atrial Flutter
- Associated Therapies
- -
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
- Conditions
- Interventions
- First Posted Date
- 2020-12-19
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 83
- Registration Number
- NCT04675788
- Locations
- 🇺🇸
Indiana Clinical Research Center, Indianapolis, Indiana, United States
🇺🇸Purdue University, Indianapolis, Indiana, United States
🇺🇸Indiana University, Indianapolis, Indiana, United States
Reducing the Risk of Drug-Induced QT Interval Lengthening in Women
- Conditions
- Interventions
- First Posted Date
- 2019-02-08
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 16
- Registration Number
- NCT03834883
- Locations
- 🇺🇸
Indiana University, Indianapolis, Indiana, United States
ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization
- Conditions
- Interventions
- First Posted Date
- 2017-12-12
- Last Posted Date
- 2020-02-10
- Lead Sponsor
- Vivek Reddy
- Target Recruit Count
- 1
- Registration Number
- NCT03370536
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes
- Conditions
- Interventions
- First Posted Date
- 2015-08-03
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 14
- Registration Number
- NCT02513940
- Locations
- 🇺🇸
Indiana University, Indianapolis, Indiana, United States
Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening
- Conditions
- Interventions
- First Posted Date
- 2013-08-27
- Last Posted Date
- 2015-10-30
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 19
- Registration Number
- NCT01929083
- Locations
- 🇺🇸
Indiana Clinical Research Center, Indianapolis, Indiana, United States
🇺🇸Purdue University, Indianapolis, Indiana, United States
Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation
- Conditions
- Interventions
- First Posted Date
- 2009-11-17
- Last Posted Date
- 2018-02-14
- Lead Sponsor
- Vivek Reddy
- Target Recruit Count
- 200
- Registration Number
- NCT01014741
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Regional Cardiology Associates, Sacramento, California, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.